nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—TYMS—Fluorouracil—skin cancer	0.29	0.362	CbGbCtD
Trimethoprim—CYP2C8—Vismodegib—skin cancer	0.0926	0.116	CbGbCtD
Trimethoprim—CYP2C9—Vismodegib—skin cancer	0.0646	0.0806	CbGbCtD
Trimethoprim—ABCB1—Vismodegib—skin cancer	0.0627	0.0782	CbGbCtD
Trimethoprim—CYP3A4—Temozolomide—skin cancer	0.0542	0.0676	CbGbCtD
Trimethoprim—CYP3A4—Imiquimod—skin cancer	0.0542	0.0676	CbGbCtD
Trimethoprim—CYP3A4—Vismodegib—skin cancer	0.0376	0.0469	CbGbCtD
Trimethoprim—ABCB1—Dactinomycin—skin cancer	0.0329	0.0411	CbGbCtD
Trimethoprim—CYP2C8—Fluorouracil—skin cancer	0.0329	0.0411	CbGbCtD
Trimethoprim—CYP3A4—Vemurafenib—skin cancer	0.0297	0.0371	CbGbCtD
Trimethoprim—CYP2C9—Fluorouracil—skin cancer	0.0229	0.0286	CbGbCtD
Trimethoprim—ABCB1—Docetaxel—skin cancer	0.017	0.0212	CbGbCtD
Trimethoprim—CYP3A4—Docetaxel—skin cancer	0.0102	0.0127	CbGbCtD
Trimethoprim—TYMS—Sorafenib—Vismodegib—skin cancer	0.00288	0.584	CbGdCrCtD
Trimethoprim—TYMS—Paclitaxel—Docetaxel—skin cancer	0.00205	0.416	CbGdCrCtD
Trimethoprim—Stomatitis—Bleomycin—skin cancer	0.0006	0.00315	CcSEcCtD
Trimethoprim—Loss of consciousness—Imiquimod—skin cancer	0.000595	0.00313	CcSEcCtD
Trimethoprim—Cough—Imiquimod—skin cancer	0.000591	0.0031	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00059	0.0031	CcSEcCtD
Trimethoprim—Haematuria—Bleomycin—skin cancer	0.000587	0.00308	CcSEcCtD
Trimethoprim—Convulsion—Imiquimod—skin cancer	0.000587	0.00308	CcSEcCtD
Trimethoprim—Ataxia—Fluorouracil—skin cancer	0.000584	0.00307	CcSEcCtD
Trimethoprim—Pneumonia—Dactinomycin—skin cancer	0.000578	0.00303	CcSEcCtD
Trimethoprim—Arthralgia—Imiquimod—skin cancer	0.000577	0.00303	CcSEcCtD
Trimethoprim—Myalgia—Imiquimod—skin cancer	0.000577	0.00303	CcSEcCtD
Trimethoprim—Anxiety—Imiquimod—skin cancer	0.000575	0.00302	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000573	0.00301	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000569	0.00299	CcSEcCtD
Trimethoprim—Decreased appetite—Vemurafenib—skin cancer	0.000563	0.00296	CcSEcCtD
Trimethoprim—Stomatitis—Dactinomycin—skin cancer	0.00056	0.00294	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00056	0.00294	CcSEcCtD
Trimethoprim—Constipation—Vemurafenib—skin cancer	0.000554	0.00291	CcSEcCtD
Trimethoprim—Pancytopenia—Temozolomide—skin cancer	0.000553	0.00291	CcSEcCtD
Trimethoprim—Neutropenia—Temozolomide—skin cancer	0.000545	0.00286	CcSEcCtD
Trimethoprim—Shock—Imiquimod—skin cancer	0.000544	0.00286	CcSEcCtD
Trimethoprim—Nervous system disorder—Imiquimod—skin cancer	0.000542	0.00285	CcSEcCtD
Trimethoprim—Skin disorder—Imiquimod—skin cancer	0.000537	0.00282	CcSEcCtD
Trimethoprim—Agranulocytosis—Dactinomycin—skin cancer	0.000536	0.00282	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Temozolomide—skin cancer	0.000532	0.00279	CcSEcCtD
Trimethoprim—Eosinophilia—Fluorouracil—skin cancer	0.000531	0.00279	CcSEcCtD
Trimethoprim—Anorexia—Imiquimod—skin cancer	0.000527	0.00277	CcSEcCtD
Trimethoprim—Pneumonia—Temozolomide—skin cancer	0.000522	0.00274	CcSEcCtD
Trimethoprim—Infestation NOS—Temozolomide—skin cancer	0.000519	0.00273	CcSEcCtD
Trimethoprim—Infestation—Temozolomide—skin cancer	0.000519	0.00273	CcSEcCtD
Trimethoprim—Depression—Temozolomide—skin cancer	0.000518	0.00272	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000515	0.00271	CcSEcCtD
Trimethoprim—Body temperature increased—Vemurafenib—skin cancer	0.000512	0.00269	CcSEcCtD
Trimethoprim—Pancytopenia—Fluorouracil—skin cancer	0.00051	0.00268	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Temozolomide—skin cancer	0.000509	0.00267	CcSEcCtD
Trimethoprim—Stomatitis—Temozolomide—skin cancer	0.000506	0.00266	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000504	0.00265	CcSEcCtD
Trimethoprim—Insomnia—Imiquimod—skin cancer	0.0005	0.00263	CcSEcCtD
Trimethoprim—Dyspnoea—Imiquimod—skin cancer	0.000493	0.00259	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Temozolomide—skin cancer	0.000491	0.00258	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Fluorouracil—skin cancer	0.00049	0.00257	CcSEcCtD
Trimethoprim—Erythema multiforme—Dactinomycin—skin cancer	0.000487	0.00256	CcSEcCtD
Trimethoprim—Dyspepsia—Imiquimod—skin cancer	0.000487	0.00256	CcSEcCtD
Trimethoprim—Pneumonia—Fluorouracil—skin cancer	0.000481	0.00253	CcSEcCtD
Trimethoprim—Erythema—Bleomycin—skin cancer	0.000481	0.00253	CcSEcCtD
Trimethoprim—Decreased appetite—Imiquimod—skin cancer	0.00048	0.00252	CcSEcCtD
Trimethoprim—Infestation NOS—Fluorouracil—skin cancer	0.000479	0.00251	CcSEcCtD
Trimethoprim—Infestation—Fluorouracil—skin cancer	0.000479	0.00251	CcSEcCtD
Trimethoprim—Hypersensitivity—Vemurafenib—skin cancer	0.000478	0.00251	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Imiquimod—skin cancer	0.000477	0.00251	CcSEcCtD
Trimethoprim—Renal impairment—Docetaxel—skin cancer	0.000471	0.00247	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Fluorouracil—skin cancer	0.000469	0.00246	CcSEcCtD
Trimethoprim—Dermatitis bullous—Docetaxel—skin cancer	0.000469	0.00246	CcSEcCtD
Trimethoprim—Stomatitis—Fluorouracil—skin cancer	0.000466	0.00245	CcSEcCtD
Trimethoprim—Hallucination—Temozolomide—skin cancer	0.000464	0.00244	CcSEcCtD
Trimethoprim—Urinary tract disorder—Temozolomide—skin cancer	0.00046	0.00242	CcSEcCtD
Trimethoprim—Pruritus—Vemurafenib—skin cancer	0.000459	0.00241	CcSEcCtD
Trimethoprim—Connective tissue disorder—Temozolomide—skin cancer	0.000458	0.00241	CcSEcCtD
Trimethoprim—Lethargy—Docetaxel—skin cancer	0.000457	0.0024	CcSEcCtD
Trimethoprim—Urethral disorder—Temozolomide—skin cancer	0.000457	0.0024	CcSEcCtD
Trimethoprim—Feeling abnormal—Imiquimod—skin cancer	0.000455	0.00239	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Imiquimod—skin cancer	0.000452	0.00237	CcSEcCtD
Trimethoprim—Epistaxis—Fluorouracil—skin cancer	0.000451	0.00237	CcSEcCtD
Trimethoprim—Hyponatraemia—Docetaxel—skin cancer	0.00045	0.00236	CcSEcCtD
Trimethoprim—Erythema—Dactinomycin—skin cancer	0.000449	0.00236	CcSEcCtD
Trimethoprim—Agranulocytosis—Fluorouracil—skin cancer	0.000447	0.00235	CcSEcCtD
Trimethoprim—Diarrhoea—Vemurafenib—skin cancer	0.000443	0.00233	CcSEcCtD
Trimethoprim—Erythema multiforme—Temozolomide—skin cancer	0.000441	0.00232	CcSEcCtD
Trimethoprim—Urticaria—Imiquimod—skin cancer	0.000439	0.00231	CcSEcCtD
Trimethoprim—Abdominal pain—Imiquimod—skin cancer	0.000437	0.0023	CcSEcCtD
Trimethoprim—Body temperature increased—Imiquimod—skin cancer	0.000437	0.0023	CcSEcCtD
Trimethoprim—Eye disorder—Temozolomide—skin cancer	0.000436	0.00229	CcSEcCtD
Trimethoprim—Tinnitus—Temozolomide—skin cancer	0.000435	0.00228	CcSEcCtD
Trimethoprim—Leukopenia—Bleomycin—skin cancer	0.000431	0.00226	CcSEcCtD
Trimethoprim—Dizziness—Vemurafenib—skin cancer	0.000429	0.00225	CcSEcCtD
Trimethoprim—Ataxia—Docetaxel—skin cancer	0.000421	0.00221	CcSEcCtD
Trimethoprim—Immune system disorder—Temozolomide—skin cancer	0.000421	0.00221	CcSEcCtD
Trimethoprim—Mediastinal disorder—Temozolomide—skin cancer	0.00042	0.00221	CcSEcCtD
Trimethoprim—Cough—Bleomycin—skin cancer	0.00042	0.00221	CcSEcCtD
Trimethoprim—Vomiting—Vemurafenib—skin cancer	0.000412	0.00216	CcSEcCtD
Trimethoprim—Myalgia—Bleomycin—skin cancer	0.00041	0.00215	CcSEcCtD
Trimethoprim—Rash—Vemurafenib—skin cancer	0.000409	0.00215	CcSEcCtD
Trimethoprim—Mental disorder—Temozolomide—skin cancer	0.000408	0.00215	CcSEcCtD
Trimethoprim—Dermatitis—Vemurafenib—skin cancer	0.000408	0.00214	CcSEcCtD
Trimethoprim—Hypersensitivity—Imiquimod—skin cancer	0.000407	0.00214	CcSEcCtD
Trimethoprim—Headache—Vemurafenib—skin cancer	0.000406	0.00213	CcSEcCtD
Trimethoprim—Malnutrition—Temozolomide—skin cancer	0.000406	0.00213	CcSEcCtD
Trimethoprim—Erythema—Temozolomide—skin cancer	0.000406	0.00213	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000404	0.00212	CcSEcCtD
Trimethoprim—Leukopenia—Dactinomycin—skin cancer	0.000402	0.00211	CcSEcCtD
Trimethoprim—Confusional state—Bleomycin—skin cancer	0.000396	0.00208	CcSEcCtD
Trimethoprim—Anaphylactic shock—Bleomycin—skin cancer	0.000393	0.00206	CcSEcCtD
Trimethoprim—Pruritus—Imiquimod—skin cancer	0.000391	0.00205	CcSEcCtD
Trimethoprim—Nausea—Vemurafenib—skin cancer	0.000385	0.00202	CcSEcCtD
Trimethoprim—Thrombocytopenia—Bleomycin—skin cancer	0.000384	0.00202	CcSEcCtD
Trimethoprim—Myalgia—Dactinomycin—skin cancer	0.000382	0.00201	CcSEcCtD
Trimethoprim—Tremor—Temozolomide—skin cancer	0.00038	0.002	CcSEcCtD
Trimethoprim—Diarrhoea—Imiquimod—skin cancer	0.000378	0.00199	CcSEcCtD
Trimethoprim—Anorexia—Bleomycin—skin cancer	0.000374	0.00197	CcSEcCtD
Trimethoprim—Erythema—Fluorouracil—skin cancer	0.000374	0.00196	CcSEcCtD
Trimethoprim—Agitation—Temozolomide—skin cancer	0.000373	0.00196	CcSEcCtD
Trimethoprim—Angioedema—Temozolomide—skin cancer	0.000371	0.00195	CcSEcCtD
Trimethoprim—DHFR—nipple—skin cancer	0.000369	0.106	CbGeAlD
Trimethoprim—Pancytopenia—Docetaxel—skin cancer	0.000368	0.00193	CcSEcCtD
Trimethoprim—Dizziness—Imiquimod—skin cancer	0.000366	0.00192	CcSEcCtD
Trimethoprim—Vertigo—Temozolomide—skin cancer	0.000365	0.00192	CcSEcCtD
Trimethoprim—Leukopenia—Temozolomide—skin cancer	0.000363	0.00191	CcSEcCtD
Trimethoprim—Neutropenia—Docetaxel—skin cancer	0.000362	0.0019	CcSEcCtD
Trimethoprim—Thrombocytopenia—Dactinomycin—skin cancer	0.000359	0.00188	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000358	0.00188	CcSEcCtD
Trimethoprim—Cough—Temozolomide—skin cancer	0.000354	0.00186	CcSEcCtD
Trimethoprim—Convulsion—Temozolomide—skin cancer	0.000352	0.00185	CcSEcCtD
Trimethoprim—Vomiting—Imiquimod—skin cancer	0.000351	0.00185	CcSEcCtD
Trimethoprim—Dyspnoea—Bleomycin—skin cancer	0.00035	0.00184	CcSEcCtD
Trimethoprim—Anorexia—Dactinomycin—skin cancer	0.000349	0.00183	CcSEcCtD
Trimethoprim—Rash—Imiquimod—skin cancer	0.000348	0.00183	CcSEcCtD
Trimethoprim—Dermatitis—Imiquimod—skin cancer	0.000348	0.00183	CcSEcCtD
Trimethoprim—Pneumonia—Docetaxel—skin cancer	0.000347	0.00183	CcSEcCtD
Trimethoprim—Headache—Imiquimod—skin cancer	0.000346	0.00182	CcSEcCtD
Trimethoprim—Myalgia—Temozolomide—skin cancer	0.000346	0.00182	CcSEcCtD
Trimethoprim—Arthralgia—Temozolomide—skin cancer	0.000346	0.00182	CcSEcCtD
Trimethoprim—Infestation NOS—Docetaxel—skin cancer	0.000345	0.00181	CcSEcCtD
Trimethoprim—Infestation—Docetaxel—skin cancer	0.000345	0.00181	CcSEcCtD
Trimethoprim—Anxiety—Temozolomide—skin cancer	0.000344	0.00181	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000343	0.0018	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000342	0.0018	CcSEcCtD
Trimethoprim—Decreased appetite—Bleomycin—skin cancer	0.000341	0.00179	CcSEcCtD
Trimethoprim—Renal failure—Docetaxel—skin cancer	0.000339	0.00178	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Docetaxel—skin cancer	0.000339	0.00178	CcSEcCtD
Trimethoprim—Stomatitis—Docetaxel—skin cancer	0.000337	0.00177	CcSEcCtD
Trimethoprim—Leukopenia—Fluorouracil—skin cancer	0.000335	0.00176	CcSEcCtD
Trimethoprim—Confusional state—Temozolomide—skin cancer	0.000334	0.00175	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000334	0.00175	CcSEcCtD
Trimethoprim—Anaphylactic shock—Temozolomide—skin cancer	0.000331	0.00174	CcSEcCtD
Trimethoprim—Nausea—Imiquimod—skin cancer	0.000328	0.00172	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Docetaxel—skin cancer	0.000327	0.00172	CcSEcCtD
Trimethoprim—Epistaxis—Docetaxel—skin cancer	0.000326	0.00171	CcSEcCtD
Trimethoprim—Nervous system disorder—Temozolomide—skin cancer	0.000325	0.00171	CcSEcCtD
Trimethoprim—Thrombocytopenia—Temozolomide—skin cancer	0.000324	0.0017	CcSEcCtD
Trimethoprim—Convulsion—Fluorouracil—skin cancer	0.000324	0.0017	CcSEcCtD
Trimethoprim—Feeling abnormal—Bleomycin—skin cancer	0.000324	0.0017	CcSEcCtD
Trimethoprim—Agranulocytosis—Docetaxel—skin cancer	0.000322	0.00169	CcSEcCtD
Trimethoprim—Skin disorder—Temozolomide—skin cancer	0.000322	0.00169	CcSEcCtD
Trimethoprim—Myalgia—Fluorouracil—skin cancer	0.000318	0.00167	CcSEcCtD
Trimethoprim—Decreased appetite—Dactinomycin—skin cancer	0.000318	0.00167	CcSEcCtD
Trimethoprim—Anorexia—Temozolomide—skin cancer	0.000316	0.00166	CcSEcCtD
Trimethoprim—Urticaria—Bleomycin—skin cancer	0.000312	0.00164	CcSEcCtD
Trimethoprim—Body temperature increased—Bleomycin—skin cancer	0.00031	0.00163	CcSEcCtD
Trimethoprim—Confusional state—Fluorouracil—skin cancer	0.000308	0.00162	CcSEcCtD
Trimethoprim—Urinary tract disorder—Docetaxel—skin cancer	0.000306	0.00161	CcSEcCtD
Trimethoprim—Anaphylactic shock—Fluorouracil—skin cancer	0.000305	0.0016	CcSEcCtD
Trimethoprim—Connective tissue disorder—Docetaxel—skin cancer	0.000305	0.0016	CcSEcCtD
Trimethoprim—Urethral disorder—Docetaxel—skin cancer	0.000304	0.0016	CcSEcCtD
Trimethoprim—Feeling abnormal—Dactinomycin—skin cancer	0.000302	0.00159	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000302	0.00159	CcSEcCtD
Trimethoprim—Insomnia—Temozolomide—skin cancer	0.0003	0.00157	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Dactinomycin—skin cancer	0.000299	0.00157	CcSEcCtD
Trimethoprim—Nervous system disorder—Fluorouracil—skin cancer	0.000299	0.00157	CcSEcCtD
Trimethoprim—Thrombocytopenia—Fluorouracil—skin cancer	0.000299	0.00157	CcSEcCtD
Trimethoprim—Dyspnoea—Temozolomide—skin cancer	0.000295	0.00155	CcSEcCtD
Trimethoprim—Erythema multiforme—Docetaxel—skin cancer	0.000293	0.00154	CcSEcCtD
Trimethoprim—Dyspepsia—Temozolomide—skin cancer	0.000292	0.00153	CcSEcCtD
Trimethoprim—Anorexia—Fluorouracil—skin cancer	0.000291	0.00153	CcSEcCtD
Trimethoprim—Eye disorder—Docetaxel—skin cancer	0.00029	0.00152	CcSEcCtD
Trimethoprim—Abdominal pain—Dactinomycin—skin cancer	0.000289	0.00152	CcSEcCtD
Trimethoprim—Body temperature increased—Dactinomycin—skin cancer	0.000289	0.00152	CcSEcCtD
Trimethoprim—Hypersensitivity—Bleomycin—skin cancer	0.000289	0.00152	CcSEcCtD
Trimethoprim—Decreased appetite—Temozolomide—skin cancer	0.000288	0.00151	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Temozolomide—skin cancer	0.000286	0.0015	CcSEcCtD
Trimethoprim—Constipation—Temozolomide—skin cancer	0.000283	0.00149	CcSEcCtD
Trimethoprim—Immune system disorder—Docetaxel—skin cancer	0.00028	0.00147	CcSEcCtD
Trimethoprim—Mediastinal disorder—Docetaxel—skin cancer	0.000279	0.00147	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000278	0.00146	CcSEcCtD
Trimethoprim—Pruritus—Bleomycin—skin cancer	0.000278	0.00146	CcSEcCtD
Trimethoprim—Insomnia—Fluorouracil—skin cancer	0.000276	0.00145	CcSEcCtD
Trimethoprim—Feeling abnormal—Temozolomide—skin cancer	0.000273	0.00143	CcSEcCtD
Trimethoprim—Dyspnoea—Fluorouracil—skin cancer	0.000272	0.00143	CcSEcCtD
Trimethoprim—Mental disorder—Docetaxel—skin cancer	0.000272	0.00143	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Temozolomide—skin cancer	0.000271	0.00142	CcSEcCtD
Trimethoprim—Malnutrition—Docetaxel—skin cancer	0.00027	0.00142	CcSEcCtD
Trimethoprim—Erythema—Docetaxel—skin cancer	0.00027	0.00142	CcSEcCtD
Trimethoprim—Hypersensitivity—Dactinomycin—skin cancer	0.00027	0.00142	CcSEcCtD
Trimethoprim—Dyspepsia—Fluorouracil—skin cancer	0.000269	0.00141	CcSEcCtD
Trimethoprim—Decreased appetite—Fluorouracil—skin cancer	0.000265	0.00139	CcSEcCtD
Trimethoprim—TYMS—connective tissue—skin cancer	0.000264	0.0762	CbGeAlD
Trimethoprim—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000263	0.00138	CcSEcCtD
Trimethoprim—Urticaria—Temozolomide—skin cancer	0.000263	0.00138	CcSEcCtD
Trimethoprim—Body temperature increased—Temozolomide—skin cancer	0.000262	0.00138	CcSEcCtD
Trimethoprim—Abdominal pain—Temozolomide—skin cancer	0.000262	0.00138	CcSEcCtD
Trimethoprim—DHFR—connective tissue—skin cancer	0.000261	0.0755	CbGeAlD
Trimethoprim—Feeling abnormal—Fluorouracil—skin cancer	0.000251	0.00132	CcSEcCtD
Trimethoprim—Diarrhoea—Dactinomycin—skin cancer	0.000251	0.00132	CcSEcCtD
Trimethoprim—Vomiting—Bleomycin—skin cancer	0.00025	0.00131	CcSEcCtD
Trimethoprim—Rash—Bleomycin—skin cancer	0.000248	0.0013	CcSEcCtD
Trimethoprim—Dermatitis—Bleomycin—skin cancer	0.000247	0.0013	CcSEcCtD
Trimethoprim—Hypersensitivity—Temozolomide—skin cancer	0.000244	0.00128	CcSEcCtD
Trimethoprim—Urticaria—Fluorouracil—skin cancer	0.000242	0.00127	CcSEcCtD
Trimethoprim—Syncope—Docetaxel—skin cancer	0.000242	0.00127	CcSEcCtD
Trimethoprim—Leukopenia—Docetaxel—skin cancer	0.000242	0.00127	CcSEcCtD
Trimethoprim—Body temperature increased—Fluorouracil—skin cancer	0.000241	0.00127	CcSEcCtD
Trimethoprim—TYMS—skin of body—skin cancer	0.000238	0.0688	CbGeAlD
Trimethoprim—Loss of consciousness—Docetaxel—skin cancer	0.000237	0.00125	CcSEcCtD
Trimethoprim—Cough—Docetaxel—skin cancer	0.000236	0.00124	CcSEcCtD
Trimethoprim—Pruritus—Temozolomide—skin cancer	0.000234	0.00123	CcSEcCtD
Trimethoprim—Convulsion—Docetaxel—skin cancer	0.000234	0.00123	CcSEcCtD
Trimethoprim—Nausea—Bleomycin—skin cancer	0.000233	0.00123	CcSEcCtD
Trimethoprim—Vomiting—Dactinomycin—skin cancer	0.000233	0.00122	CcSEcCtD
Trimethoprim—Rash—Dactinomycin—skin cancer	0.000231	0.00121	CcSEcCtD
Trimethoprim—Myalgia—Docetaxel—skin cancer	0.00023	0.00121	CcSEcCtD
Trimethoprim—Arthralgia—Docetaxel—skin cancer	0.00023	0.00121	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000228	0.0012	CcSEcCtD
Trimethoprim—Diarrhoea—Temozolomide—skin cancer	0.000227	0.00119	CcSEcCtD
Trimethoprim—Hypersensitivity—Fluorouracil—skin cancer	0.000225	0.00118	CcSEcCtD
Trimethoprim—Confusional state—Docetaxel—skin cancer	0.000222	0.00117	CcSEcCtD
Trimethoprim—Anaphylactic shock—Docetaxel—skin cancer	0.00022	0.00116	CcSEcCtD
Trimethoprim—Dizziness—Temozolomide—skin cancer	0.000219	0.00115	CcSEcCtD
Trimethoprim—Nausea—Dactinomycin—skin cancer	0.000218	0.00114	CcSEcCtD
Trimethoprim—TYMS—mammalian vulva—skin cancer	0.000217	0.0628	CbGeAlD
Trimethoprim—Shock—Docetaxel—skin cancer	0.000217	0.00114	CcSEcCtD
Trimethoprim—Nervous system disorder—Docetaxel—skin cancer	0.000216	0.00113	CcSEcCtD
Trimethoprim—Pruritus—Fluorouracil—skin cancer	0.000216	0.00113	CcSEcCtD
Trimethoprim—Thrombocytopenia—Docetaxel—skin cancer	0.000216	0.00113	CcSEcCtD
Trimethoprim—DHFR—mammalian vulva—skin cancer	0.000215	0.0621	CbGeAlD
Trimethoprim—Skin disorder—Docetaxel—skin cancer	0.000214	0.00112	CcSEcCtD
Trimethoprim—Vomiting—Temozolomide—skin cancer	0.000211	0.00111	CcSEcCtD
Trimethoprim—Anorexia—Docetaxel—skin cancer	0.00021	0.0011	CcSEcCtD
Trimethoprim—Rash—Temozolomide—skin cancer	0.000209	0.0011	CcSEcCtD
Trimethoprim—Diarrhoea—Fluorouracil—skin cancer	0.000209	0.0011	CcSEcCtD
Trimethoprim—Dermatitis—Temozolomide—skin cancer	0.000209	0.0011	CcSEcCtD
Trimethoprim—Headache—Temozolomide—skin cancer	0.000208	0.00109	CcSEcCtD
Trimethoprim—Dizziness—Fluorouracil—skin cancer	0.000202	0.00106	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000201	0.00105	CcSEcCtD
Trimethoprim—Insomnia—Docetaxel—skin cancer	0.000199	0.00105	CcSEcCtD
Trimethoprim—Nausea—Temozolomide—skin cancer	0.000197	0.00103	CcSEcCtD
Trimethoprim—Dyspnoea—Docetaxel—skin cancer	0.000196	0.00103	CcSEcCtD
Trimethoprim—Vomiting—Fluorouracil—skin cancer	0.000194	0.00102	CcSEcCtD
Trimethoprim—Dyspepsia—Docetaxel—skin cancer	0.000194	0.00102	CcSEcCtD
Trimethoprim—TYMS—lymphoid tissue—skin cancer	0.000193	0.0557	CbGeAlD
Trimethoprim—Rash—Fluorouracil—skin cancer	0.000192	0.00101	CcSEcCtD
Trimethoprim—Dermatitis—Fluorouracil—skin cancer	0.000192	0.00101	CcSEcCtD
Trimethoprim—Decreased appetite—Docetaxel—skin cancer	0.000191	0.00101	CcSEcCtD
Trimethoprim—Headache—Fluorouracil—skin cancer	0.000191	0.001	CcSEcCtD
Trimethoprim—DHFR—lymphoid tissue—skin cancer	0.000191	0.0552	CbGeAlD
Trimethoprim—Gastrointestinal disorder—Docetaxel—skin cancer	0.00019	0.000999	CcSEcCtD
Trimethoprim—Constipation—Docetaxel—skin cancer	0.000188	0.00099	CcSEcCtD
Trimethoprim—TYMS—female reproductive system—skin cancer	0.000186	0.0538	CbGeAlD
Trimethoprim—DHFR—female reproductive system—skin cancer	0.000184	0.0532	CbGeAlD
Trimethoprim—Feeling abnormal—Docetaxel—skin cancer	0.000182	0.000954	CcSEcCtD
Trimethoprim—Nausea—Fluorouracil—skin cancer	0.000181	0.000952	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Docetaxel—skin cancer	0.00018	0.000946	CcSEcCtD
Trimethoprim—Abdominal pain—Docetaxel—skin cancer	0.000174	0.000915	CcSEcCtD
Trimethoprim—Body temperature increased—Docetaxel—skin cancer	0.000174	0.000915	CcSEcCtD
Trimethoprim—Hypersensitivity—Docetaxel—skin cancer	0.000162	0.000853	CcSEcCtD
Trimethoprim—Pruritus—Docetaxel—skin cancer	0.000156	0.000819	CcSEcCtD
Trimethoprim—TYMS—head—skin cancer	0.000156	0.0449	CbGeAlD
Trimethoprim—DHFR—head—skin cancer	0.000154	0.0445	CbGeAlD
Trimethoprim—Diarrhoea—Docetaxel—skin cancer	0.000151	0.000792	CcSEcCtD
Trimethoprim—Dizziness—Docetaxel—skin cancer	0.000146	0.000765	CcSEcCtD
Trimethoprim—Vomiting—Docetaxel—skin cancer	0.00014	0.000736	CcSEcCtD
Trimethoprim—Rash—Docetaxel—skin cancer	0.000139	0.00073	CcSEcCtD
Trimethoprim—Dermatitis—Docetaxel—skin cancer	0.000139	0.000729	CcSEcCtD
Trimethoprim—Headache—Docetaxel—skin cancer	0.000138	0.000725	CcSEcCtD
Trimethoprim—Nausea—Docetaxel—skin cancer	0.000131	0.000687	CcSEcCtD
Trimethoprim—ABCB1—blood vessel—skin cancer	0.000121	0.035	CbGeAlD
Trimethoprim—TYMS—lymph node—skin cancer	0.000109	0.0314	CbGeAlD
Trimethoprim—DHFR—lymph node—skin cancer	0.000108	0.0311	CbGeAlD
Trimethoprim—CYP2C8—female reproductive system—skin cancer	9.15e-05	0.0264	CbGeAlD
Trimethoprim—CYP2C9—female reproductive system—skin cancer	8.13e-05	0.0235	CbGeAlD
Trimethoprim—CYP3A4—female reproductive system—skin cancer	6.2e-05	0.0179	CbGeAlD
Trimethoprim—ABCB1—epithelium—skin cancer	5.91e-05	0.0171	CbGeAlD
Trimethoprim—ABCB1—mammalian vulva—skin cancer	5.12e-05	0.0148	CbGeAlD
Trimethoprim—ABCB1—lymphoid tissue—skin cancer	4.55e-05	0.0131	CbGeAlD
Trimethoprim—ABCB1—female reproductive system—skin cancer	4.39e-05	0.0127	CbGeAlD
Trimethoprim—ABCB1—head—skin cancer	3.67e-05	0.0106	CbGeAlD
Trimethoprim—ABCB1—lymph node—skin cancer	2.57e-05	0.00741	CbGeAlD
